320 related articles for article (PubMed ID: 19153411)
1. High-density lipoprotein particle size and concentration and coronary risk.
El Harchaoui K; Arsenault BJ; Franssen R; Després JP; Hovingh GK; Stroes ES; Otvos JD; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
Ann Intern Med; 2009 Jan; 150(2):84-93. PubMed ID: 19153411
[TBL] [Abstract][Full Text] [Related]
2. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
El Harchaoui K; van der Steeg WA; Stroes ES; Kuivenhoven JA; Otvos JD; Wareham NJ; Hutten BA; Kastelein JJ; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2007 Feb; 49(5):547-53. PubMed ID: 17276177
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
van der Steeg WA; Holme I; Boekholdt SM; Larsen ML; Lindahl C; Stroes ES; Tikkanen MJ; Wareham NJ; Faergeman O; Olsson AG; Pedersen TR; Khaw KT; Kastelein JJ
J Am Coll Cardiol; 2008 Feb; 51(6):634-42. PubMed ID: 18261682
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study.
van Capelleveen JC; Bernelot Moens SJ; Yang X; Kastelein JJP; Wareham NJ; Zwinderman AH; Stroes ESG; Witztum JL; Hovingh GK; Khaw KT; Boekholdt SM; Tsimikas S
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1206-1212. PubMed ID: 28473441
[TBL] [Abstract][Full Text] [Related]
5. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
6. High-Density Lipoprotein Subclasses, Coronary Artery Disease, and Cardiovascular Mortality.
Silbernagel G; Pagel P; Pfahlert V; Genser B; Scharnagl H; Kleber ME; Delgado G; Ohrui H; Ritsch A; Grammer TB; Koenig W; März W
Clin Chem; 2017 Dec; 63(12):1886-1896. PubMed ID: 29021325
[TBL] [Abstract][Full Text] [Related]
7. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
[TBL] [Abstract][Full Text] [Related]
8. HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Arsenault BJ; Lemieux I; Després JP; Gagnon P; Wareham NJ; Stroes ES; Kastelein JJ; Khaw KT; Boekholdt SM
Atherosclerosis; 2009 Sep; 206(1):276-81. PubMed ID: 19268944
[TBL] [Abstract][Full Text] [Related]
9. Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Rip J; Nierman MC; Wareham NJ; Luben R; Bingham SA; Day NE; van Miert JN; Hutten BA; Kastelein JJ; Kuivenhoven JA; Khaw KT; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):637-42. PubMed ID: 16373616
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease.
Birjmohun RS; Dallinga-Thie GM; Kuivenhoven JA; Stroes ES; Otvos JD; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
Circulation; 2007 Oct; 116(18):2029-35. PubMed ID: 17923573
[TBL] [Abstract][Full Text] [Related]
11. Comparison of high-density and low-density lipoprotein cholesterol subclasses and sizes in Asian Indian women with Caucasian women from the Framingham Offspring Study.
Bhalodkar NC; Blum S; Rana T; Kitchappa R; Bhalodkar AN; Enas EA
Clin Cardiol; 2005 May; 28(5):247-51. PubMed ID: 15971461
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
[TBL] [Abstract][Full Text] [Related]
13. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.
Gardner CD; Fortmann SP; Krauss RM
JAMA; 1996 Sep; 276(11):875-81. PubMed ID: 8782636
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
Boekholdt SM; Kuivenhoven JA; Wareham NJ; Peters RJ; Jukema JW; Luben R; Bingham SA; Day NE; Kastelein JJ; Khaw KT
Circulation; 2004 Sep; 110(11):1418-23. PubMed ID: 15337694
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.
Stampfer MJ; Krauss RM; Ma J; Blanche PJ; Holl LG; Sacks FM; Hennekens CH
JAMA; 1996 Sep; 276(11):882-8. PubMed ID: 8782637
[TBL] [Abstract][Full Text] [Related]
18. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
Blake GJ; Otvos JD; Rifai N; Ridker PM
Circulation; 2002 Oct; 106(15):1930-7. PubMed ID: 12370215
[TBL] [Abstract][Full Text] [Related]
20. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
